Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

4.53
Delayed Data
As of Sep 04
 -0.06 / -1.31%
Today’s Change
4.25
Today|||52-Week Range
12.88
-51.76%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Clifford Tracy Simmons
Principal Accounting Officer
Sale10/28/201412,754$10.00$127.5K-54.24%
Drysdale Douglas L
Chief Executive Officer
Buy5/06/201516,000$6.40$102.4K-29.66%
Clifford Tracy Simmons
Principal Accounting Officer
Buy10/28/201412,754$3.80$48.5K-54.24%
Drysdale Douglas L
Chief Executive Officer
Buy8/18/20158,500$4.69$39.9K-2.58%
Patel Sanjay S
Chief Financial Officer
Buy8/19/20155,000$4.60$23.0K-5.43%
Clifford Tracy Simmons
Principal Accounting Officer
Sale11/03/20142,246$10.00$22.5K-54.01%
Siegel Barry J
General Counsel & Senior Vice President
Buy8/19/20155,000$4.49$22.5K-5.43%
Patel Sanjay S
Chief Financial Officer
Buy5/06/20152,000$6.42$12.8K-29.66%
Clifford Tracy Simmons
Principal Accounting Officer
Buy11/03/20142,246$3.80$8.5K-54.01%
Dorsey Brian T
Senior Vice President-Research
Gift10/10/201433,333$0.00$0.00-44.76%
Page of 2